非经常性损益

港股IPO招股书披露先例 · 311 家公司,348 项

非经常性损益指一次性或非经常发生并影响期间业绩的事项,如廉价购买收益、出售收益、大额汇兑损益及政府补助增减等。申请人一般在概要、业务、财务资料及风险因素章节披露其性质、金额及对毛利率、其他收入等指标的影响,并说明剔除一次性项目后的基线、相关事项不再重现或补偿负债已结清,将波动归因于业务性质、汇率波动或战略举措。

2026-06-12Application Proof

2025年出售附属公司一次性收益30万美元

Our other net income increased from US$0.3 million for the year ended December 31, 2024 to US$0.9 million for the year ended December 31, 2025, primarily due to our gains on disposal of 100% equity interest in Nanping Guduoduo to a third party in 2025 with nil consideration.

Financial Information · 第 220 页

On the date of disposal, Nanping Guduoduo had net liabilities of US$0.3 million and a cash balance of US$36 thousand, resulting in a net gain of US$0.3 million and a cash outflow of US$36 thousand.

Financial Information · 第 220 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2026-06-12Application Proof
宁波三星医疗电气股份有限公司NINGBO SANXING MEDICAL ELECTRIC CO., LTD.

2025年其他收入及收益大增含多项一次性项目

Our other income and gains increased by 62.1% from RMB461.8 million in 2024 to RMB748.7 million in 2025, primarily driven by (i) a fair value gain on financial assets at FVTPL of RMB204.1 million in 2025, compared to nil in 2024; (ii) net foreign exchange gains of RMB139.4 million in 2025, compared to nil in 2024 (as net foreign exchange losses of RMB111.9 million in 2024 were recorded as other expenses) as a result of exchange rate fluctuation; and (iii) performance compensation of RMB39.9 million related to prior year acquisitions of subsidiaries and RMB26.6 million related to prior year acquisition of non-controlling interests in a subsidiary because the relevant acquired entities failed to meet their performance targets as stipulated in the acquisition agreements.

Financial Information · 第 209 页

Our other income and gains decreased by 2.8% from RMB475.1 million in 2023 to RMB461.8 million in 2024, primarily driven by the absence of fair value gains on financial assets at FVTPL (which amounted to RMB143.7 million in 2023) and the absence of gain on disposal of a subsidiary (which amounted to RMB51.0 million in 2023), partially offset by an increase of RMB66.2 million in government grants.

Financial Information · 第 211 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2026-06-12Prospectus
深圳市星源材质科技股份有限公司Shenzhen Senior Technology Material Co., Ltd.06067.HK

2025年存货核销损失2,971万元属一次性

Loss on write-off of inventories recognized in other losses and gains related to unforeseeable event outside the ordinary course of our business and was non-recurring in nature.

Financial Information · 第 233 页

Our other gains decreased by 49.0% from RMB36.5 million in 2024 to RMB18.6 million in 2025, primarily due to (i) the recognition of impairment losses on property, plant and equipment relating to the cessation of production in Shenzhen manufacturing base in the last quarter of 2025, and (ii) recognition of loss on write-off of inventories, mainly due to equipment malfunction at certain storage facilities that temporarily compromised the required storage environment, rendering the affected inventories unsaleable, partially offset by an increase in investment income of financial assets at FVTPL, mainly from equity investment.

Financial Information · 第 237 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2026-06-12Application Proof
主线科技(北京)股份有限公司Trunk Technology (Beijing) Co., Ltd.

2023年赎回负债修改一次性收益1,410万元

The gains in 2023 was primarily attributable to the recognition of a gain of RMB14.1 million resulting from a re-measurement of the fair value of redemption liabilities to reflect the non-substantial modification of the redemption rights between our Company and the [REDACTED] Investors in October 2023.

Financial Information · 第 226 页

Represent a non-cash, non-recurring accounting gain recognized in 2023 as a result of the remeasurement of redemption liabilities following the amendment to the redemption period agreed between the Company and the [REDACTED] Investors.

Summary · 第 7 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2026-06-11Application Proof
广东奥迪威传感科技股份有限公司Audiowell Electronics (Guangdong) Co., Ltd.

其他收入2025年大跌71.8%

Our other income and other gains and losses decreased by RMB21.1 million, or 71.8%, from RMB29.4 million in 2024 to RMB8.3 million in 2025, primarily due to (i) a decrease of RMB6.3 million gain on dilution of the investment in an associate and (ii) a change from foreign exchange gains of RMB4.0 million in 2024 to foreign exchange losses of RMB4.1 million in 2025 as RMB appreciated against the U.S. dollar in 2025, following a depreciation in 2024.

Financial Information · 第 212 页

Our other income and other gains and losses increased by RMB8.4 million, or 40.3%, from RMB21.0 million in 2023 to RMB29.4 million in 2024, primarily due to (i) a RMB6.3 million gain on dilution of the investment in an associate in 2024 and (ii) an increase of RMB3.9 million in government subsidies as we met relevant technological improvement policy requirements and received the corresponding government support.

Financial Information · 第 215 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2026-06-10Application Proof
深圳市丰宜科技集团股份有限公司Shenzhen Fengyi Technology Group Co., Ltd.

2023年确认递延税项资产1.143亿元

In 2023, 2024 and 2025, we recorded income tax credit of RMB114.9 million, RMB25.1 million and RMB32.7 million, respectively, arising from tax losses available for deduction.

Financial Information · 第 183 页

Our income tax credit decreased from RMB114.9 million in 2023 to RMB25.1 million in 2024, primarily because we recognized deferred tax assets of RMB114.3 million in 2023 in connection with our accumulated losses as of December 31, 2023, while the deferred tax assets of RMB24.6 million recognized in 2024 were only related to tax losses incurred in 2024.

Financial Information · 第 186 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2026-06-10Application Proof
派想未来集团PPLabs Technology Limited

2025年出售设备收益推高其他收入113%

Our other income and gains increased by 113.0% from RMB7.5 million in 2024 to RMB15.9 million in 2025, primarily because we recorded gains on disposal of property, plant and equipment of RMB4.5 million in 2025 as we disposed of certain equipments relating to our edge cloud computing services in order to optimize our asset portfolio and improve overall asset utilization.

Financial Information · 第 231 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2026-06-08Application Proof
杭州高光制药股份有限公司Hangzhou Highlightll Pharmaceutical Co., Ltd.

政府补助变动致其他收入大幅波动

Our other net income increased from RMB6.4 million in 2024 to RMB20.4 million in 2025, primarily due to an increase of RMB17.0 million in government grants in relation with our research and development activities.

Financial Information · 第 235 页

We recorded other net income of RMB10.1 million in the three months ended March 31, 2025, while we recorded other net loss of RMB1.0 million in the three months ended March 31, 2026, primarily due to (i) a decrease of RMB8.7 million in government grants, and (ii) a net exchange loss of RMB3.0 million recorded in the three months ended March 31, 2026, which was mainly attributable to fluctuations in the exchange rate between the U.S. dollar and Renminbi.

Financial Information · 第 234 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2026-06-05Application Proof
沪士电子股份有限公司WUS Printed Circuit (Kunshan) Co., Ltd.

汇兑损益致其他收益净额大幅波动

We recorded net other gains in the three months ended March 31, 2025 while we recorded net other losses in the three months ended March 31, 2026, primarily due to net foreign exchange losses of RMB147.1 million recognized in the three months ended March 31, 2026 as compared to net foreign exchange gains in the same period in 2025, driven by exchange losses on our USD-denominated assets resulting from the depreciation of USD against RMB in the same periods.

Financial Information · 第 197 页

The fluctuations of our net other gains/(losses) during the Track Record Period was in line with changes in net foreign exchange gains or losses as a result of exchange rate fluctuations.

Financial Information · 第 197 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2026-05-31Application Proof
成都卡诺普机器人技术股份有限公司Chengdu CRP Robot Technology Co., Ltd.

2023年一次性政府补助致其他收益波动

During the Track Record Period, we received government grants other than deferred income of RMB20.7 million, RMB10.1 million and RMB9.8 million in 2023, 2024 and 2025, respectively. The decrease from 2023 to 2024 was primarily due to the single large grant made by the Chengdu government based on a "one project, one decision" policy in an amount of RMB10.5 million, as a means to support major local companies.

Financial Information · 第 225 页

Our other income and gains decreased by 38.1% from RMB26.7 million in 2023 to RMB16.5 million in 2024, mainly due to a decrease in government grants recognized during the year of RMB10.5 million.

Financial Information · 第 233 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2026-05-29Application Proof
广州市易鸿智能装备股份有限公司Guangzhou EHolly Intelligent Equipment Co., Ltd.

2023年出售固态电池公司股权收益660万元

During the Track Record Period, our other income and gains primarily consisted of (i) government grants, (ii) bank interest income, (iii) gains on disposal of an investment measured at FVTPL, which primarily related to our disposal of shares in a solid-state battery company in 2023, and (iv) others.

Financial Information · 第 201 页

This decrease was primarily due to (i) a decrease of RMB6.6 million in gains on disposal of an investment measured at FVTPL, as we disposed of shares in a solid-state battery company in 2023; (ii) a decrease of RMB6.4 million in government grants, and (iii) a decrease of RMB2.7 million in bank interest income, as a result of lower prevailing bank interest rates and a reduction in time deposit activities as we redirected funds to support our operating activities.

Financial Information · 第 209 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2026-05-29Application Proof
浙江中国小商品城集团股份有限公司Zhejiang China Commodities City Group Co., Ltd.

2023年宾王市场拆迁补偿致处置收益1.391亿元

In 2023, the government demolished the Binwang Market and revoked the land use rights, in consideration of which it provided demolition compensation to our Company.

Financial Information · 第 221 页

Other gains, net decreased by 44.7% from RMB221.3 million in 2023 to RMB122.5 million in 2024, primarily due to (i) the absence of provisions reversed in 2024, and (ii) a decrease in net gains/ (losses) on disposal of property, plant and equipment and other long-term assets.

Financial Information · 第 228 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2026-05-29Application Proof
浙江中国小商品城集团股份有限公司Zhejiang China Commodities City Group Co., Ltd.

2023年转回信用证或有负债拨备1.106亿元

In 2018, after our Company and the Trading Company were sued, the provision was adjusted to RMB110,620,000 based on the claim amount asserted in the lawsuit.

Financial Information · 第 221 页

Accordingly, the provision for contingent liabilities previously recognized by our Company was reversed in 2023.

Financial Information · 第 221 页

Other gains, net decreased by 44.7% from RMB221.3 million in 2023 to RMB122.5 million in 2024, primarily due to (i) the absence of provisions reversed in 2024, and (ii) a decrease in net gains/ (losses) on disposal of property, plant and equipment and other long-term assets.

Financial Information · 第 228 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2026-05-29Application Proof
地上铁绿色科技(深圳)股份有限公司DST Sustainable Technology (Shenzhen) Co., Ltd.

2024年一次性联营公司处置收益1.01亿元

In December 2024, we exchanged equity interest in an associate for shares of an equity investment, resulting in investment income of RMB101.0 million in 2024.

Financial Information · 第 197 页

The decrease was primarily due to a decrease in the gain on disposal of associates and joint ventures attributable to the one-off gain on the associate disposal in 2024, which was not recurring in 2025, and such decrease was partially offset by an increase in gains from fair value changes of financial assets at FVTPL.

Financial Information · 第 203 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2026-05-29Application Proof
真实生物科技有限公司Genuine Biotech Limited

2024年确认复星一次性生产成本补贴1.211亿元

Our other income and gains decreased significantly from RMB146.7 million in 2024 to RMB6.2 million in 2025, primarily attributable to (i) a decrease in subsidy for production costs.

Financial Information · 第 251 页

We recorded one-off subsidy for production costs of RMB121.1 million in 2024, representing the compensation of production costs from Fosun Pharmaceutical Industrial in respect of a significant amount of azvudine produced in early 2023 in light of the then COVID situation and expected demands of our products.

Financial Information · 第 251 页

No such amount was recorded in 2025; and (ii) the decrease in government grants from RMB21.7 million in 2024 to RMB5.8 million in 2025.

Financial Information · 第 251 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2026-05-29Application Proof

出售理想汽车股份收益逐年大幅下降

Our other gains, net decreased from RMB1,302.1 million in 2023 to RMB303.1 million in 2024, primarily due to the decrease in the number of shares in Li Auto we disposed in 2024, resulting in the decreased gain on disposal of financial assets at FVTPL.

Financial Information · 第 243 页

Our other gains, net decreased from RMB303.1 million in 2024 to RMB156.0 million in 2025, primarily due to (i) a reduction of RMB120.6 million in gains on disposal of financial assets at FVTPL, resulting from a lower disposal volume of Li Auto shares, bonds, and notes in 2025 compared to 2024; and (ii) an increase of RMB18.6 million in net losses on disposal of property, plant and equipment and other long-term assets, primarily related to the disposal of certain investments accounted for using the equity method that no longer aligned with our long-term holding strategy.

Financial Information · 第 243 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2026-05-27Application Proof
爱尔眼科医院集团股份有限公司Aier Eye Hospital Group Co., Ltd.

政府补助减少致2025年其他收入下降44.9%

Our other income decreased by 44.9% from RMB258.4 million in 2024 to RMB142.4 million in 2025, primarily due to a decrease of RMB140.1 million in government grants, as we received certain one-off government subsidies in 2024 which decreased in 2025.

Financial Information · 第 232 页

Our other income primarily consisted of (i) government grants, mainly represented one-off incentives provided by local government to support our daily business operations; (ii) investment income from financial assets at FVTPL and debt securities at amortized cost; (iii) income from wealth management products; and (iv) others, primarily comprise refund of handling fees for individual income tax.

Financial Information · 第 227 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2026-05-27Application Proof
科望医药集团Elpiscience Biopharmaceuticals, Inc.

2025年其他收入及收益减少45.4%

Foreign exchange gains, net | 8,319 | –

Financial Information · 第 245 页

Our other income and gains decreased by 45.4% from RMB35.3 million in 2024 to RMB19.3 million in 2025, primarily due to a decrease in bank interest income resulting from lower average bank deposit balances, and a reduction in net foreign exchange gains attributable to fluctuations in foreign exchange rates.

Financial Information · 第 250 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2026-05-27Application Proof
爱士惟科技股份有限公司AISWEI Technology Co., Ltd.

汇兑收益波动导致其他收入大幅波动

Our foreign exchange gains remained relatively stable at RMB30.6 million 2023 and at RMB35.4 million in 2025 resulting from the appreciation of the Euros against Renminbi, while our foreign exchange gains were nil in 2024 resulting from the depreciation of the Euros against Renminbi.

Financial Information · 第 173 页

Our other income and gains increased significantly from RMB29.9 million in 2024 to RMB81.7 million in 2025, primarily due to foreign exchange gains of RMB35.4 million in 2025 attributable to the appreciation of Euros against Renminbi, whereas no such foreign exchange gains were recognized in 2024.

Financial Information · 第 177 页

Our other income and gains decreased by 47.0% from RMB56.4 million in 2023 to RMB29.9 million in 2024, primarily due to foreign exchange gains of RMB30.6 million in 2023 attributable to the appreciation of Euros against Renminbi, whereas no such foreign exchange gains were recognized in 2024.

Financial Information · 第 178 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看

Tell us